Saturday 17 October 2026
Export NMAD’s income statement to Excel — free account
Nomad Power Solutions, Inc.
NMAD Healthcare Biotechnology
In the quarter to June 2026, EPS grew 44.8% and free cash flow fell 230.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
3.88
0.21
−5.13%
Follow NMAD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (68.04%) | (213.84%) | (185.41%) | (3,661.47%) |
+8 more TTM periods Free account |
|
| (62.67%) | (118.11%) | (87.60%) | (115.96%) | ||
ROIC |
(40.41%) | (67.35%) | (54.52%) | (120.30%) | |
Return on Tangible Assets |
(49.00%) | (334.91%) | (158.08%) | (84.15%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(0.40) | (0.40) | (0.63) | (0.42) | |
Free Cash Flow |
(5.46) | (4.33) | (3.07) | (2.58) | |
| Other line items | |||||
Cash ROIC |
(14.49%) | (34.87%) | (19.11%) | (33.09%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(959.42) | (694.36) | (555.17) | (397.61) | |
Operating CF/Net income |
0.63 | 0.59 | 0.51 | 0.62 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.40) | (0.40) | (0.63) | (0.42) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates